Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

East Asian Regulators Collaborate To Reduce Drug Lags (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

[Editor's note: This is part two of a two-part story. The first part appeared in PharmAsia News, April 17, 2008.]

You may also be interested in...



Japan Launches ‘Safety Net’ Initiative As PMDA Looks To Resolve Drug Lag With The West (part 1 of 2)

Risk management program follows drug from first-in-human to post-market, gathering safety data.

Japan Launches ‘Safety Net’ Initiative As PMDA Looks To Resolve Drug Lag With The West (part 1 of 2)

Risk management program follows drug from first-in-human to post-market, gathering safety data.

Japan Launches ‘Safety Net’ Initiative As PMDA Looks To Resolve Drug Lag With The West (Part 1 of 2)

TOKYO - Japan's Pharmaceuticals and Medical Devices Agency has started a new pilot program for risk management, tentatively being called the "product management" initiative. Under the initiative, a group will be created within PMDA's Office of Safety to oversee a new drug throughout its life cycle. Initial plans called for only a handful of drugs being involved. The agency hopes to finish the pilot program within six months, in time for the initiative to be operational some time in the spring

Related Content

UsernamePublicRestriction

Register

ID1132380

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel